中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model

文献类型:期刊论文

作者Zhang, Ruxue2,3; Zhang, Yumin2; Zheng, Wei1,3; Shang, Weijuan2; Wu, Yan2; Li, Ning4; Xiong, Jun4; Jiang, Hualiang1,3; Shen, Jingshan3; Xiao, Gengfu2,3
刊名SIGNAL TRANSDUCTION AND TARGETED THERAPY
出版日期2022-04-16
卷号7期号:1页码:3
ISSN号2095-9907
DOI10.1038/s41392-022-00963-7
通讯作者Xie, Yuanchao(xieyuanchao@simm.ac.cn) ; Zhang, Leike(zhangleike@wh.iov.cn)
WOS关键词DISCOVERY
资助项目National Natural Science Foundation of China[31970165] ; National Key Research and Development Program of China[2021YFC2300700] ; Shanghai Municipal Science and Technology Major Project ; Youth Innovation Promotion Association CAS[2018367]
WOS研究方向Biochemistry & Molecular Biology ; Cell Biology
语种英语
WOS记录号WOS:000782897800001
出版者SPRINGERNATURE
源URL[http://119.78.100.183/handle/2S10ELR8/299794]  
专题中国科学院上海药物研究所
通讯作者Xie, Yuanchao; Zhang, Leike
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Ctr Biosafety Mega Sci, Wuhan 430071, Peoples R China
3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
4.Shanghai Junshi Biosci Co Ltd, Shanghai 200126, Peoples R China
5.Lingang Lab, Shanghai 200031, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Ruxue,Zhang, Yumin,Zheng, Wei,et al. Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY,2022,7(1):3.
APA Zhang, Ruxue.,Zhang, Yumin.,Zheng, Wei.,Shang, Weijuan.,Wu, Yan.,...&Zhang, Leike.(2022).Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model.SIGNAL TRANSDUCTION AND TARGETED THERAPY,7(1),3.
MLA Zhang, Ruxue,et al."Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model".SIGNAL TRANSDUCTION AND TARGETED THERAPY 7.1(2022):3.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。